News + Filings Transactions
|
Ros Matthew
| Date | Name | Symbol | Type | Security | Shares | Price | Value | Ownership | Reported |
| 10/02/2023 | Cogent Biosciences, Inc. | UMRX | Grant | Stock Option (Right to Buy) | 2.2k | $9.55 | $20.7k | | 10/02/2023 |
| 07/03/2023 | Cogent Biosciences, Inc. | UMRX | Grant | Stock Option (Right to Buy) | 1.7k | $11.96 | $20.8k | | 07/03/2023 |
| 06/07/2023 | Cogent Biosciences, Inc. | UMRX | Grant | Stock Option (Right to Buy) | 36.7k | $11.70 | $429.4k | | 06/07/2023 |
| 04/03/2023 | Cogent Biosciences, Inc. | UMRX | Grant | Stock Option (Right to Buy) | 1.9k | $10.75 | $20.4k | | 04/03/2023 |
| 01/03/2023 | Cogent Biosciences, Inc. | UMRX | Grant | Stock Option (Right to Buy) | 1.8k | $11.07 | $19.8k | | 01/03/2023 |
| 10/03/2022 | Cogent Biosciences, Inc. | UMRX | Grant | Stock Option (Right to Buy) | 1.4k | $14.33 | $20.3k | | 10/03/2022 |
| 07/01/2022 | Cogent Biosciences, Inc. | UMRX | Grant | Stock Option (Right to Buy) | 2.2k | $9.39 | $20.6k | | 07/01/2022 |
| 06/07/2022 | Cogent Biosciences, Inc. | UMRX | Grant | Stock Option (Right to Buy) | 30.7k | $4.59 | $140.9k | | 06/07/2022 |
| 04/01/2022 | Cogent Biosciences, Inc. | UMRX | Grant | Stock Option (Right to Buy) | 2.6k | $7.92 | $21k | | 04/01/2022 |
| 01/03/2022 | Cogent Biosciences, Inc. | UMRX | Grant | Stock Option (Right to Buy) | 2.3k | $8.70 | $19.6k | | 01/03/2022 |
| 10/01/2021 | Cogent Biosciences, Inc. | UMRX | Grant | Stock Option (Right to Buy) | 2.5k | $8.54 | $21k | | 10/01/2021 |
| 07/01/2021 | Cogent Biosciences, Inc. | UMRX | Grant | Stock Option (Right to Buy) | 2.2k | $8.02 | $17.8k | | 07/01/2021 |
| 04/01/2021 | Cogent Biosciences, Inc. | UMRX | Grant | Stock Option (Right to Buy) | 2.1k | $9.08 | $18.8k | | 04/01/2021 |
| 03/11/2021 | Cogent Biosciences, Inc. | UMRX | Grant | Stock Option (Right to Buy) | 60k | $8.45 | $507k | | 03/11/2021 |
| 02/04/2021 | Epizyme, Inc. | EPZM | Sale | Common Stock, par value $0.0001 | 894 | $11.21 | $10k | | 02/04/2021 |
| 02/01/2021 | Epizyme, Inc. | EPZM | Grant | Common Stock | 28.1k | $0.00 | $0 | | 02/01/2021 |
| 02/01/2021 | Epizyme, Inc. | EPZM | Grant | Stock Option (Right to Buy) | 134.2k | $11.02 | $1.5M | | 02/01/2021 |
| 01/25/2021 | Epizyme, Inc. | EPZM | Sale | Common Stock, par value $0.0001 | 2.9k | $11.41 | $32.8k | | 01/25/2021 |
| 01/04/2021 | Cogent Biosciences, Inc. | UMRX | Grant | Stock Option (Right to Buy) | 1.6k | $7.62 | $12.5k | | 01/04/2021 |
| 10/01/2020 | Cogent Biosciences, Inc. | UMRX | Grant | Stock Option (Right to Buy) | 9.2k | $2.26 | $20.9k | | 10/01/2020 |
| 07/01/2020 | Cogent Biosciences, Inc. | UMRX | Grant | Stock Option (Right to Buy) | 35.3k | $0.47 | $16.6k | | 07/01/2020 |
| 06/26/2020 | Epizyme, Inc. | EPZM | Sale | Common Stock, par value $0.0001 | 2.7k | $16.15 | $44.1k | | 06/25/2020 |
| 06/25/2020 | Epizyme, Inc. | EPZM | Grant | Common Stock, par value $0.0001 | 6k | $0.00 | $0 | | 06/25/2020 |
| 06/18/2020 | Epizyme, Inc. | EPZM | Exercise | Stock Option (Right to Buy) | 41.1k | $9.12 | $374.5k | | 06/18/2020 |
| 06/18/2020 | Epizyme, Inc. | EPZM | Sale | Common Stock, par value $0.0001 | 68.7k | $21.65 | $1.5M | | 06/18/2020 |
| 06/18/2020 | Epizyme, Inc. | EPZM | Sale | Common Stock, par value $0.0001 | 2.3k | $22.00 | $50.4k | | 06/18/2020 |
| 06/18/2020 | Epizyme, Inc. | EPZM | Exercise | Stock Option (Right to Buy) | 2.3k | $12.45 | $28.5k | | 06/18/2020 |
| 06/18/2020 | Epizyme, Inc. | EPZM | Exercise | Stock Option (Right to Buy) | 68.7k | $9.58 | $657.7k | | 06/18/2020 |
| 06/18/2020 | Epizyme, Inc. | EPZM | Sale | Common Stock, par value $0.0001 | 41.1k | $20.50 | $841.8k | | 06/18/2020 |
| 06/09/2020 | Cogent Biosciences, Inc. | UMRX | Grant | Stock Option (Right to Buy) | 14.3k | $0.63 | $9k | | 06/09/2020 |
| 04/06/2020 | Cogent Biosciences, Inc. | UMRX | Grant | Stock Option (Right to Buy) | 49.9k | $0.35 | $17.4k | | 04/06/2020 |
| 03/25/2020 | Epizyme, Inc. | EPZM | Sale | Common Stock, par value $0.0001 | 1.2k | $15.28 | $19k | | 03/24/2020 |
| 03/24/2020 | Epizyme, Inc. | EPZM | Grant | Common Stock, par value $0.0001 | 1.6k | $0.00 | $0 | | 03/24/2020 |
| 03/24/2020 | Epizyme, Inc. | EPZM | Grant | Common Stock, par value $0.0001 | 4k | $0.00 | $0 | | 03/24/2020 |
| 02/03/2020 | Epizyme, Inc. | EPZM | Grant | Common Stock | 11.7k | $0.00 | $0 | | 02/03/2020 |
|
|